Elisabeth F Mock, MD | |
489 State St, Bangor, ME 04401-6616 | |
(207) 973-6252 | |
(207) 973-5042 |
Full Name | Elisabeth F Mock |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 27 Years |
Location | 489 State St, Bangor, Maine |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578533543 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD16379 (Maine) | Secondary |
208M00000X | Hospitalist | MD16379 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Eastern Maine Medical Center | Bangor, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eastern Maine Medical Center | 2062315161 | 577 |
News Archive
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
Theravance, Inc. today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 5635(c)(4), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to facilitate the granting of equity awards to new employees.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.
Workplace violence perpetrated by military personnel is a major concern of the U.S. Department of Defense. Although programs have been implemented to teach violence prevention strategies to all military personnel, such programs are much less intensive than others developed in settings for people judged to be at high risk of violent behavior.
Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the new report from the International Treatment Preparedness Coalition, documents early warning signs resulting from the global pullback on AIDS commitment and funding: caps on the number of people enrolled in treatment programs, more frequent drug stock outs, and national AIDS budgets falling short.
› Verified 5 days ago
Entity Name | Eastern Maine Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790789147 PECOS PAC ID: 2062315161 Enrollment ID: O20040128000088 |
News Archive
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
Theravance, Inc. today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 5635(c)(4), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to facilitate the granting of equity awards to new employees.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.
Workplace violence perpetrated by military personnel is a major concern of the U.S. Department of Defense. Although programs have been implemented to teach violence prevention strategies to all military personnel, such programs are much less intensive than others developed in settings for people judged to be at high risk of violent behavior.
Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the new report from the International Treatment Preparedness Coalition, documents early warning signs resulting from the global pullback on AIDS commitment and funding: caps on the number of people enrolled in treatment programs, more frequent drug stock outs, and national AIDS budgets falling short.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Elisabeth F Mock, MD 43 Whiting Hill Rd, Ste 300, Brewer, ME 04412-1005 Ph: (207) 973-5035 | Elisabeth F Mock, MD 489 State St, Bangor, ME 04401-6616 Ph: (207) 973-6252 |
News Archive
Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.
Theravance, Inc. today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 5635(c)(4), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to facilitate the granting of equity awards to new employees.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has received its first purchase order for DAVANAT from PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. Pro-Pharmaceuticals has received a purchase order for $200,000 which will be the upfront payment for this first shipment of DAVANAT.
Workplace violence perpetrated by military personnel is a major concern of the U.S. Department of Defense. Although programs have been implemented to teach violence prevention strategies to all military personnel, such programs are much less intensive than others developed in settings for people judged to be at high risk of violent behavior.
Rationing Funds, Risking Lives: World Backtracks on HIV Treatment, the new report from the International Treatment Preparedness Coalition, documents early warning signs resulting from the global pullback on AIDS commitment and funding: caps on the number of people enrolled in treatment programs, more frequent drug stock outs, and national AIDS budgets falling short.
› Verified 5 days ago
Dr. Leonard C Moneke, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Dr. James M Mccarthy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Dr. Alexandra Craig, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 992 Union St, Bangor, ME 04401 Phone: 207-945-5247 | |
Dr. Savitha Rajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7000 Fax: 207-973-5042 | |
Pradeep S Paul, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3215 Fax: 207-907-1795 | |
Toyiba Hussain Syed, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-6252 Fax: 207-973-5042 | |
Keith Amit Singh, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-6605 Fax: 207-973-4441 |